Salami F, Shad T, Fathi N, Mojtahedi H, Esmaeili M, Shahkarami S
J Clin Immunol. 2025; 45(1):67.
PMID: 39853455
PMC: 11762072.
DOI: 10.1007/s10875-025-01857-3.
Nuijens A, Oei A, Franken N, Rasch C, Stalpers L
Curr Oncol. 2025; 32(1).
PMID: 39851963
PMC: 11763857.
DOI: 10.3390/curroncol32010047.
Lim H, Lim H, Yoo H
Int J Mol Sci. 2024; 25(23).
PMID: 39684807
PMC: 11642328.
DOI: 10.3390/ijms252313097.
Mi L, Zhang H
Open Life Sci. 2024; 19(1):20220992.
PMID: 39655194
PMC: 11627069.
DOI: 10.1515/biol-2022-0992.
Xu Y, Li C, Yin H, Nowsheen S, Xu X, Kang W
Nucleic Acids Res. 2024; 52(22):13881-13895.
PMID: 39588777
PMC: 11662673.
DOI: 10.1093/nar/gkae1099.
Phased chromosome-level genome provides insights into the molecular adaptation for migratory lifestyle and population diversity for Pacific saury, Cololabis saira.
Liu Y, Luo Y, Wang P, Li W, Tian H, Cao C
Commun Biol. 2024; 7(1):1513.
PMID: 39543266
PMC: 11564879.
DOI: 10.1038/s42003-024-07126-0.
Plasma Proteomics of Type 2 Diabetes, Hypertension, and Co-Existing Diabetes/Hypertension in Thai Adults.
Fakfum P, Chuljerm H, Parklak W, Roytrakul S, Phaonakrop N, Lerttrakarnnon P
Life (Basel). 2024; 14(10).
PMID: 39459569
PMC: 11509282.
DOI: 10.3390/life14101269.
Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases.
Choi A, DAgostino Jr R, Farris M, Abdulhaleem M, Hunting J, Wang Y
Front Endocrinol (Lausanne). 2024; 15:1364021.
PMID: 39355617
PMC: 11443040.
DOI: 10.3389/fendo.2024.1364021.
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variants.
Richardson M, Holdren M, Brannan T, de la Hoya M, Spurdle A, Tavtigian S
Am J Hum Genet. 2024; 111(11):2411-2426.
PMID: 39317201
PMC: 11568761.
DOI: 10.1016/j.ajhg.2024.08.022.
Proteomic assessment of SKBR3/HER2+ breast cancer cellular response to Lapatinib and investigational Ipatasertib kinase inhibitors.
Karcini A, Mercier N, Lazar I
Front Pharmacol. 2024; 15:1413818.
PMID: 39268460
PMC: 11391243.
DOI: 10.3389/fphar.2024.1413818.
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study.
Krasniqi E, Ercolani C, Di Benedetto A, Di Lisa F, Filomeno L, Arcuri T
Cancers (Basel). 2024; 16(15).
PMID: 39123356
PMC: 11311544.
DOI: 10.3390/cancers16152628.
NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance.
Chen H, Li Y, Li H, Chen X, Fu H, Mao D
Nature. 2024; 631(8021):663-669.
PMID: 38961290
PMC: 11254748.
DOI: 10.1038/s41586-024-07620-9.
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline sequence variants.
Richardson M, Holdren M, Brannan T, de la Hoya M, Spurdle A, Tavtigian S
medRxiv. 2024; .
PMID: 38854136
PMC: 11160822.
DOI: 10.1101/2024.05.28.24307502.
Proteomic Assessment of SKBR3/HER2+ Breast Cancer Cellular Response to Lapatinib and Investigational Ipatasertib Kinase Inhibitors.
Karcini A, Mercier N, Lazar I
bioRxiv. 2024; .
PMID: 38617302
PMC: 11014527.
DOI: 10.1101/2024.04.02.587656.
Computational Analysis of Non-synonymous SNPs in ATM Kinase: Structural Insights, Functional Implications, and Inhibitor Discovery.
Panchal N, Samdani P, Sengupta T, Prince S
Mol Biotechnol. 2024; 67(3):1201-1221.
PMID: 38489015
DOI: 10.1007/s12033-024-01120-x.
Targeting ATR Pathway in Solid Tumors: Evidence of Improving Therapeutic Outcomes.
Mavroeidi D, Georganta A, Panagiotou E, Syrigos K, Souliotis V
Int J Mol Sci. 2024; 25(5).
PMID: 38474014
PMC: 10932434.
DOI: 10.3390/ijms25052767.
A-T neurodegeneration and DNA damage-induced transcriptional stress.
Paull T, Woolley P
DNA Repair (Amst). 2024; 135():103647.
PMID: 38377644
PMC: 11707827.
DOI: 10.1016/j.dnarep.2024.103647.
Mycotoxin source and its exposure causing mycotoxicoses.
Nawaf A
Bioinformation. 2023; 19(4):348-357.
PMID: 37822835
PMC: 10563570.
DOI: 10.6026/97320630019348.
Bone Marrow Failure and Immunodeficiency Associated with Human RAD50 Variants.
Takagi M, Hoshino A, Bousset K, Roddecke J, Martin H, Folcut I
J Clin Immunol. 2023; 43(8):2136-2145.
PMID: 37794136
DOI: 10.1007/s10875-023-01591-8.
FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA.
Geng Y, Long X, Zhang Y, Wang Y, You G, Guo W
J Transl Med. 2023; 21(1):652.
PMID: 37737187
PMC: 10515429.
DOI: 10.1186/s12967-023-04461-4.